Download Unicorn Signals App

By EquityPandit

EquityPandit

EquityPandit
MARKETS

Kirloskar Pneumatic Revenue Decline for Q1; Shares Falls by 2%

Kirloskar Pneumatic shares are down by 2%, the company reports an 11.04% decline in operational revenue at Rs 242 crore.

Kirloskar Pneumatic shares are down by 2% on July 20 as the company reported an 11.04% decline in its operational revenue at Rs 242.22 crore against its Rs 272.28 crore reported in the corresponding quarter of the previous fiscal year.

Kirloskar Pneumatic Limited is a subsidiary of the Kirloskar Group; the company primarily manufactures air compressors, industrial gas systems, and compressed air systems. The company has also ventured into developing wind turbine gearboxes and transmission mechanisms for railways.

The net profit for the current quarter was up by 10% at Rs 17.93 crore, while the company reported Rs 16.15 crore in Q1FY23.

The company reported a decline in profit after taxes, barring the non-operational other income, by 15.5% YoY to Rs 12.19 crore against Rs 14.44 crore in Q1FY23. In contrast, after taxes securing other income, the profit was down by 58.6% against the previous quarter.

EBITDA margins stood at 13% of the current quarter’s total income, up by 210 basis points from 10.9% in the previous fiscal year.

At 3:30 market close, the stock closed at Rs 646.05 apiece, down by 1.99% or Rs 13.10 on NSE.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
MARKETS

Delhivery Shares Trade Green on Ecom Acquisition News 

Ali Waghbakriwala

The share price of Delhivery Ltd, a logistics company, was trading in the green and 4% higher, hitting an intraday high of Rs 271.30 on Monday, 7 April 2025, in spite of the overall market collapse. 

The Delhivery share price increased after the firm declared that it had finalised a deal to buy a majority share in Ecom Express Limited for approximately Rs 1,400 crore in cash from its shareholders.

Ecom Express provides complete logistics solutions driven by technology to the Indian retail and e-commerce industries. The company was established in 2012 and provides first-mile pickup, processing, network operation, last-mile delivery, reverse logistics, and returns management under its primary offering, Ecom Express Services. 

Sahil Barua, MD and CEO of Delhivery, said: “We believe this acquisition will enable us to service customers of both companies better through continued bold investments in infrastructure, technology, network and people. The founders and management of Ecom Express have established a high-quality network and team, creating a strong foundation to integrate into Delhivery’s operations.” 

According to Delhivery, the acquisition will be completed subject to Competition Commission of India (CCI) approval and typical closing conditions. 

On the deal, K Satyanarayana, founder of Ecom Express, said: “Delhivery is among India’s leading fully integrated logistics service providers with significant scale advantages and will be the ideal shareholder for Ecom Express’ next phase of growth. With this acquisition and its inherent synergies, businesses across India as well as the logistics industry itself will benefit immensely through the combination of two like-minded players.” 

The acquisition is being done at a trailing enterprise value (EV)/Sales ratio of 0.7x, which appears attractive when compared to Delhivery’s current 1.7x ratio. 

Delhivery will most likely be able to reduce Ecom Express’s long-haul transportation costs by shifting freight to larger trucks in its fleet. The combined business will receive a sizable amount of the higher profits, which is expected to boost the industry’s overall profit stream.

According to analysts, key negative risks to the target price and rating include an e-commerce industry downturn, inability to efficiently use assets to improve profitability, severe competition, and a faster-than-expected pricing fall.

At 3:30 pm, the shares of Delhivery closed 4.08% higher at Rs 269.35 on NSE.

Tired of guessing stocks to trade in daily?
Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!

MARKETS

Sensex Turns Red and Sinks 5% 

Ali Waghbakriwala

On Monday, 7 April 2025, half of the 30 Sensex equities fell more than 5% on the BSE during intraday trading as Dalal Street became risk-averse following US President Donald Trump’s harsh reciprocal tariff announcement.

Among the most severely impacted stocks, the following fell between 5% and 12% in intraday trading: Tata Steel (11.5%), Tech Mahindra (8.4%), Tata Motors (10.3%; at 52-week low), Mahindra and Mahindra (9.1%), Infosys (9.9%), Sun Pharma (8.1%), IndusInd Bank (9.4%), Adani Ports (9.3%), Larsen & Toubro (8.9%), HCL Technologies (8.3%), Reliance Industries Limited (7.4%; at 52-week low), Bajaj Finance (7.1%), Kotak Mahindra Bank (8.1%), Tata Consultancy Services (7.2%; at 52-week low), and Axis Bank (5.1%).

Tata Motors’ stock price dropped 10.31% to Rs 550.55 per share as a result of its UK subsidiary Jaguar Land Rover announcing that it has ceased exporting to the US this month due to Trump’s 25% tariff on cars manufactured outside of the US.

According to JLR, the US is a significant market. However, the company has chosen to “enact” its “planned short-term actions including a shipment pause in April” in order to address the new trading terms.

Tata Steel’s share price fell 11.5% to an intraday low of Rs 124.2 due to a double whammy.  First, metal equities had substantial selling pressure on Monday as the industry-related sector was hit by concerns about global growth. China, the world’s largest metals consumer, has been slapped with a cumulative 54% tariff. China has also levied a 34% retaliatory tariff on the US.

Secondly, the Tata Group company received an income tax notice for the fiscal year 2018-19 (AY 2019-20), which increased its taxable income by Rs 25,185.51 crore.  According to Tata Steel, the value represents the debt that was waived in the company’s favour when it was given the opportunity to purchase Bhushan Steel, now known as Tata Steel BSL, under the Insolvency and Bankruptcy Code.

IndusInd Bank’s shares fell 9.4% following the bank’s March 2025 quarter update, which revealed a disappointing increase in advances. IndusInd Bank’s Q4FY25 business update indicates net advances increased by 1.4% year on year to Rs 3,47,933 crore. Loans fell by 5.2% quarter over quarter.

Reliance Industries’ share price (RIL), among other noteworthy equities, slumped 7.4% intraday to a new 52-week low of Rs 1,115.5 a share as crude oil prices plummeted due to worries about global growth. RIL, which is involved in oil sourcing and exploration, earns around 60% of its revenue from the petrochemical and oil industries.

Overall, the BSE Sensex index slid 3,939.6 points (5.2%) to an intraday low of 71,425. The precipitous decline in shares comes after a global stock market catastrophe, with investors on the defensive as a result of US President Donald Trump’s reciprocal tariffs.

Following Trump’s imposition of punitive tariffs on more than 180 countries, China and Canada announced counter-tariffs of equivalent amounts. Meanwhile, the Eurozone is pondering similar measures.

MARKETS

Nifty Pharma Bleeds Red Over Looming Tariffs Comment 

Ali Waghbakriwala

Shares of Indian pharmaceutical businesses, including Gland Pharma Ltd, Laurus Labs Ltd, Glenmark Pharmaceuticals Ltd, and Biocon Ltd, dropped as much as 8% on Monday, 7 April, in response to comments made by US President Donald Trump about the upcoming taxes on the pharmaceutical industry. The stock of other pharmaceutical businesses fell between 2% to 6% as well.

Early Monday trading saw the Nifty Pharma index fall as much as 7%, extending its year-to-date decline to 14%. After ending at 20,560, the index reached an intraday low of 19,121.10.

On 2 April, Trump proposed sweeping reciprocal tariffs over 60 countries. The pharmaceutical industry did well that day since Trump excluded it from the announcement, but the following day, he implemented limitations on medication imports into the United States.

Trump, while speaking to reporters on Air Force One, said, “Pharma tariffs are going to come in at levels you haven’t really seen before. We are looking at pharmaceuticals as a separate category. We will be announcing that sometime in the near future, and not too distant future. It’s under review right now,”.

Pharmaceutical imports from India are currently tax-free in the US. However, pharmaceutical imports from the US are subject to a 10% tariff in India.

If reciprocal tariffs are imposed on the pharmaceutical industry, they will only total 10% on imported drugs.

At 12:31 pm, Nifty Pharma was trading 2.96% lower at Rs 19,952.40.

Unlock profitable opportunities every day! Unicorn Signals provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Unicorn Signals and start winning now!

MARKETS

ONGC and Oil India shares slump over 9% as crude oil prices extend decline

Ali Waghbakriwala

Shares of state-owned oil producers ONGC and Oil India Ltd fell by more than 8% on Monday, 7 April, following a continued decline in crude oil prices over the past three days.

Crude prices tumbled at the start of the week, triggered by Saudi Arabia’s decision to significantly cut its benchmark crude price, the steepest reduction in over two years, that came amid rising concerns of a global economic slowdown fueled by intensifying trade tensions. 

Brent crude dropped nearly 4% to $63.21 per barrel, its lowest in four years, after plunging 11% the previous week. West Texas Intermediate (WTI) was trading at $59.79 per barrel.

Saudi Aramco announced it would reduce the price of Arab Light crude by $2.3 per barrel for Asian buyers in May, just days after the OPEC+ group surprised markets with a larger-than-expected increase in production.

Meanwhile, trade tensions between the US and China are adding to the uncertainty. Despite fears of inflation and recession, US officials downplayed the economic impact of the latest tariffs. In response, China, the world’s top crude importer, announced retaliatory tariffs against the US.

The slump in oil prices is being driven by both the tariff-related uncertainty and the unexpected OPEC+ output hike. US President Donald Trump also urged OPEC+ to reduce oil prices as part of efforts to lower inflation and increase pressure on Russia over the Ukraine conflict.

Falling crude prices spell trouble for oil producers like ONGC and Oil India, as it compresses their profit margins. While crude prices drop, the prices of refined products may not adjust as quickly or in proportion. This could result in inventory losses for refineries holding stock purchased at higher prices.

Altogether, weakening demand and increased supply have reignited fears of a global oil surplus.

At 11:52 am, the shares of Oil India were trading 5.53% lower at Rs 337.95, and shares of ONGC were trading 3.73% lower at Rs 217.58 on the NSE.

Discover the next big investment! Unicorn Signals’ IPO screener helps you identify promising initial public offerings. Download Unicorn Signals and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!

MARKETS

Stocks in Focus: Tata Motors, AstraZeneca Pharma India, Godrej Properties, and Others

Ali Waghbakriwala

The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 3.60% lower by 821 points at 22,138, indicating that the domestic benchmark indices are likely to make a negative start on Monday.

On Friday, 4 April, Domestic benchmark indices S&P BSE Sensex slumped by 931 points or 1.22% and settled at 75,365 while the Nifty50 traded 1.49% lower by 346 points, settling at 22,904.

Here are some stocks that are likely to remain in focus on 7 April.

Tata Motors: The company has decided to put a temporary halt on shipments to the US amid the 25% tariffs imposed on all foreign-made vehicles. 

AstraZeneca Pharma India: The company has announced securing approval from the Central Drugs Standard Control Organization to import Osimertinib tablets 40 mg & 80 mg (TAGRISSO). The Osimertinib tablets are used to treat non-small cell lung cancer in patients who have certain types of abnormal EGFR genes. 

Godrej Properties: The company has announced an agreement to develop a prime land parcel in Versova, Mumbai. The project has an estimated development potential of 4.4 lakh square feet of saleable area and has a revenue potential of Rs 1,350 crore. 

ITC: The company has announced acquiring an additional 2.62 lakh shares of Ample Foods for a total consideration of Rs 131 crore, taking its total stake in the company to 43.75%. 

Oil Companies: The shares of oil companies such as Reliance Industries, Oil India, Hindustan Oil Exploration, ONGC, and many more will be in focus today as global oil prices fall. 

Force Motors: The company announced selling 3,606 units of Small Commercial Vehicles, Utility Vehicles, Light Commercial Vehicles, and Sports Utility Vehicles in the Indian market in March 2025, highlighting an 11.02% year-on-year increase from the number reported in March 2024.

IT, Metals, Pharma Shares: The shares of information technology (IT), metals, and pharmaceuticals will remain in focus over the growing tensions over a global trade war after US President Donald Trump imposed tariffs.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

 

@2025 - www.equitypandit.com. All Right Reserved.
Latest
IPO
Weekly
Outlook

Stock
Market
Prediction